CMV Modulation of the Immune System in ANCA-associated Vasculitis

NCT01633476 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

38

Enrollment

OTHER

Sponsor class

Conditions

ANCA Associated Vasculitis
CMV Infection

Interventions

DRUG: Valaciclovir

Sponsor

Professor Lorraine Harper

Collaborators

[object Object]